MedicaidPrior AuthMedium impact
Medications for Substance Use Disorders
Connecticut Medicaid (HUSKY Health)·CT · Psychiatry, Family Medicine, Internal Medicine +1 more·Provider Bulletin
Effective date
Dec 1, 2015
We identified it
Jun 20, 2026
Summary
Connecticut Medicaid updated coverage guidelines for substance use disorder medications, specifying prior authorization requirements and prescriber restrictions. Key changes include Suboxone film being preferred without prior auth, while generic buprenorphine tablets and Vivitrol require prior authorization.
Action Required
Billing team must update prior authorization workflows for Connecticut Medicaid patients receiving substance use disorder medications. Verify Suboxone sublingual film does not require prior auth, while generic buprenorphine tablets, Vivitrol, and Evzio do require prior authorization. Update encounter forms to remind providers of prescriber restrictions (DATA waiver required for buprenorphine, ValueOptions authorization required for methadone clinic services).